Product Description
Tenofovir Alafenamide Tablets offer a reduced risk profile and are designed to personalise HIV-1 and chronic hepatitis B treatment with excellent tolerability. These majestic, film-coated tabletswhite to off-whiteare administered orally and come in a bottle containing 30 tablets. Each dosage delivers 25 mg of active Tenofovir Alafenamide, with an assay not less than 98%, ensuring ace efficacy. Developed by reputed pharmaceutical companies, these allopathic, medicine-grade tablets remain potent for 23 years and excel in supporting patient care thanks to their reduced side effect potential and premium salt composition.
Versatile Application & Commercial Value
Tenofovir Alafenamide Tablets are primarily used in the medical treatment of HIV-1 infection and chronic hepatitis B. The area of application focuses on systemic therapy via the oral route, targeting viral suppression throughout the body. These tablets are widely valued in hospitals, clinics, and pharmacies, making them an excellent choice for commercial distribution among distributor, exporter, supplier, and wholesaler networks across India and globally.
Exemplary Sample Policy & Efficient Export Logistics
We offer a premium sample policy for Tenofovir Alafenamide Tablets, with samples available to eligible healthcare and business professionals. Our logistics team ensures timely and secure dispatched shipments, maintaining optimal storage conditions throughout transit. Main export markets for this product include Asia, Africa, the Middle East, and international pharmaceutical sectors, backed by reliable and transparent procedures for both sampling and bulk purchase.
FAQs of Tenofovir Alafenamide Tablets:
Q: How should Tenofovir Alafenamide Tablets be administered for optimal results?
A: Tenofovir Alafenamide Tablets should be taken orally with or without food, as prescribed by a healthcare professional, to ensure optimal absorption and therapeutic effectiveness.
Q: What conditions do Tenofovir Alafenamide Tablets treat?
A: These tablets are indicated for the treatment of HIV-1 infection and chronic hepatitis B, helping reduce viral load and improve patient outcomes.
Q: When do Tenofovir Alafenamide Tablets expire after manufacture?
A: The expiration date for Tenofovir Alafenamide Tablets ranges from 24 to 36 months from the date of manufacture, guaranteeing efficacy within this timeframe if stored properly.
Q: Where are these tablets usually distributed and exported from?
A: Tenofovir Alafenamide Tablets are distributed and exported from India by reputed pharmaceutical companies to various global markets, including Asia, Africa, and the Middle East.
Q: What is the process for obtaining product samples?
A: Eligible clients can request samples through an established policy, with efficient processing and logistics to ensure samples are dispatched promptly and securely.
Q: What are the benefits of using Tenofovir Alafenamide over other antiretroviral agents?
A: Tenofovir Alafenamide offers a reduced risk of renal and bone side effects, enhanced tolerability, and excellent efficacy in viral suppression, making it a preferred option in antiretroviral therapy.